Short answer
Olema Pharmaceuticals, Inc. (OLMA) filed an 8-K current report with the SEC on May 12, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2026 financial results reported for the quarter ended March 31, 2026.
Olema Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 financial results reported for the quarter ended March 31, 2026
- Press release furnished as the source for detailed operating results and financial metrics
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Olema Pharmaceuticals, Inc. 8-K filings
Get the next OLMA 8-K as it lands
Follow OLMA for push alerts, or ask the research agent what this filing means.